Cartalax 20mg
(€2.94 / mg)
Research-grade lyophilized peptide powder, 20mg per glass vial.
| Ships from EU - no customs fees | Dispatch in 1–2 business days |
Research Use Only. Not for human or veterinary use.
Recommended solvent — Bacteriostatic water
In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see Bacteriostatic water.
Research Overview
Cartalax belongs to the family of short synthetic peptide bioregulators developed in Russian gerontology research. The current listing records CAS 307297-39-8 and a molecular weight of 390.35 g·mol⁻¹, and the product is a lyophilized peptide powder.
Investigators have used it in cartilage and bone cell cultures, in gene-expression profiling of musculoskeletal tissue and in studies of cellular ageing markers. Studied in vitro and in animal models; no approved clinical application in any jurisdiction.
Studied in
- Cartilage biology — chondrocyte culture models
- Bone research — osteoblast activity studies
- Gene expression — musculoskeletal transcript profiling
- Cellular ageing — senescence marker panels
Lab data
| Batch: | 260414-01 |
| Purity (measured): | 99.783 % |
| Content (measured): | 19.56 mg per vial |
| Laboratory: | Janoshik (report #163278) |
| Date of analysis: | 18.05.2026 |
| Form: | Lyophilized peptide powder |
| Packaging: | Glass vial with sterile closure |
| Storage: | Store lyophilized at 2–8 °C (desiccated, protect from light) |
| Molecular formula: | C14H22N4O9 |
| Molecular weight: | 390.35 g·mol⁻¹ |
| Sequence: | Ala-Glu-Asp-Gly (AEDG) |
| CAS: | 307297-39-8 |
Warning
This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.